| Address |
1250 Rue Guy Suite #600 Montréal, H3H 2L3 Canada |
|
| Address type | Registered Office Address | |
| Address province | Quebec |
| Corporation ID | 10173657 | |
| Business number | 721466290 | |
| Status | Active - Dissolution Pending (Non-compliance) | |
| ACT | Canada Business Corporations Act | |
| Status details | Active - Dissolution Pending (non-compliance) | |
| Anniversary date | 04/03/2017 | |
| Last annual filing | 2024 | |
| Data verified | 10/31/2026 |
Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).
| Name | Effective date | Type | Current |
|---|---|---|---|
| 10173657 CANADA INC. | 04/03/2017 | Corporate Name | |
| INViCARE INC. | 11/03/2026 | Corporate Name | true |
last updated: 2026-10-30
7 federal grants and contributions between 2018 and 2022 with a total value of $279,777.
| Start date | Department and program | Value |
|---|---|---|
| 08/01/2022 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) IP Assist: Intellectual Property Strategy Engagement The Project will support development of intellectual property capacity within the Firm. |
$2,100 |
| 07/01/2021 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Development of Innovative Nanocrystalline Biomaterials to Prevent and Treat Implant Infections. This project will allow the determination of the parameters to set up a continuous, automated scale-up production of the firm's product for transfer to a large Canadian CMO. |
$105,177 |
| 06/01/2021 |
National Research Council Canada Industrial Research Assistance Program – Youth Employment Program (contribution) Youth - Development of sterilization process for INViCARE 2D nanocrystalline technology and establishment of INViCARE's Quality Management System INViCARE developed a new class of crystalline nanomaterials with scientifically proven dental implant disinfection and bone healing properties. The project aims to develop a sterilization protocol for the manufactured gels. |
$32,500 |
| 08/01/2020 |
National Research Council Canada Industrial Research Assistance Program – Youth Employment Program (contribution) YEP - Development of innovative nanocrystalline biomaterials to prevent and treat implant infections INViCARE is a nanotechnological spin-off company of McGill University, bringing innovative and impactful biomaterials to the healthcare industry. Based on 7 years of collaborative research between McGill, Harvard, and the University of Montreal, we have successfully developed a new class of... |
$30,000 |
| 07/27/2020 |
Canada Economic Development for Quebec Regions Regional Relief and Recovery Fund (REGI-RRRF) (contribution) 400057720 Working capital : In the context of the crisis caused by the pandemic at COVID-19, the project aims to ensure the continuity of the activities of a company that specializes in the development of biomaterials for dental implants. |
$40,000 |
| 07/05/2018 |
Canada Economic Development for Quebec Regions Regional Economic Growth through Innovation Program (REGI) (contribution) 400053663 Commercialization Strategy: The project aims to commercialize a technology resulting from R&D as part of the start-up of an innovative company in the life sciences sector. |
$35,000 |
| 07/05/2018 |
Canada Economic Development for Quebec Regions Quebec Economic Development Program (QEDP) (contribution) 400053663 Commercialization Strategy: The project aims to commercialize an R&D technology as part of the start-up of an innovative company in the life sciences sector. |
$35,000 |
Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.
| Date | Type | Section |
|---|---|---|
| 07/27/2018 | Amendment | 6 |
| 04/03/2017 | Incorporation |